Bio-Rad Rival Wants Its COVID Test Tech Cleared Of IP Claims
The German molecular diagnostics provider Qiagen hit Bio-Rad Laboratories Inc. with a lawsuit in Delaware federal court Wednesday, asking a judge to declare that its QIAcuity technology used to quickly test...To view the full article, register now.
Already a subscriber? Click here to view full article